218 related articles for article (PubMed ID: 38428659)
21. Unveiling the potential mechanisms of Amomi fructus against gastric ulcers via integrating network pharmacology and in vivo experiments.
Lv Y; Li J; Li Y; Su J; Ding X; Yuan Y; Liu S; Mou Y; Li G; Zhang L
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117179. PubMed ID: 37777029
[TBL] [Abstract][Full Text] [Related]
22. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
[TBL] [Abstract][Full Text] [Related]
23. Study on molecular biological mechanism of Chinese herbal medicines for the treatment of gastric precancerous lesions based on data mining and network pharmacology.
Zhang Q; Liu N; Wu D; Xu Z; Wang Y; Wang P
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 51(5):573-584. PubMed ID: 36581572
[TBL] [Abstract][Full Text] [Related]
24. The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway.
Li M; Zhang W; Yang L; Wang H; Wang Y; Huang K; Zhang W
Dis Markers; 2021; 2021():4304507. PubMed ID: 34306252
[TBL] [Abstract][Full Text] [Related]
25. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
26. [Mechanism of Marsdenia tenacissima against ovarian cancer based on network pharmacology and experimental verification].
Hu YJ; Wei LY; Zhao J; Zhu QF; Meng ZY; Meng JJ; Chen JJ; Xu LY; Zhou YY; Han YL
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(8):2222-2232. PubMed ID: 37282910
[TBL] [Abstract][Full Text] [Related]
27. [
Gao M; Hong Y; Cui M; Huang J; Tan Y; Nie X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):1-12. PubMed ID: 35249865
[TBL] [Abstract][Full Text] [Related]
28. Molecular Targets and Mechanisms of
Yang Z; Lu S; Tang H; Qu J; Wang B; Wang Y; Pan G; Rao B
Evid Based Complement Alternat Med; 2022; 2022():6186662. PubMed ID: 35707465
[No Abstract] [Full Text] [Related]
29. [Material basis and mechanism of Huangqin Tea in prevention of colorectal cancer based on network pharmacology and molecular docking].
Wang Y; Shen J; He Q; Yang KL; He CN; Xiao PG
Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6251-6260. PubMed ID: 34951252
[TBL] [Abstract][Full Text] [Related]
30. Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer.
Huang S; Zhang Z; Li W; Kong F; Yi P; Huang J; Mao D; Peng W; Zhang S
Drug Des Devel Ther; 2020; 14():2725-2740. PubMed ID: 32764874
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of Key Ingredient of Astragalus membranaceus on Lung Adenocarcinoma via PI3K/AKT Signaling Clarified by Utilizing Network Pharmacology Approach and Experimental Validation.
Wang YC; Hui JR; Xiao G; Ma QL
Chin J Integr Med; 2023 Mar; 29(3):244-252. PubMed ID: 36044117
[TBL] [Abstract][Full Text] [Related]
32. Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Aloin Against Gastric Cancer.
Gao J; Yang S; Xie G; Pan J; Zhu F
Drug Des Devel Ther; 2022; 16():1947-1961. PubMed ID: 35757520
[TBL] [Abstract][Full Text] [Related]
33. The mechanism of Epimedium in the treatment of coronary atherosclerotic heart disease based on network pharmacology, molecular docking, and in vitro studies.
Xin G; Yuedong Y; Xuemei S; Chenhan M; Meng Z; Chenbo Z; Ning G; Xindong W
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2478-2488. PubMed ID: 35442463
[TBL] [Abstract][Full Text] [Related]
34. Exploring the Mechanism of
Zhu J; Han M; Yang Y; Feng R; Hu Y; Wang Y
Comb Chem High Throughput Screen; 2024; 27(1):157-167. PubMed ID: 37366364
[TBL] [Abstract][Full Text] [Related]
35. [Mechanism of Linderae Radix against gastric cancer based on network pharmacology and in vitro experimental validation].
Liang X; Zhang JH; Bai HT; Li YL; Sun SH; Zhang QQ; Yang J; Wang R
Zhongguo Zhong Yao Za Zhi; 2022 Sep; 47(18):5008-5021. PubMed ID: 36164911
[TBL] [Abstract][Full Text] [Related]
36. A network pharmacology approach and experimental validation to investigate the anticancer mechanism of Qi-Qin-Hu-Chang formula against colitis-associated colorectal cancer through induction of apoptosis via JNK/p38 MAPK signaling pathway.
Wu Y; Fang Y; Li Y; Au R; Cheng C; Li W; Xu F; Cui Y; Zhu L; Shen H
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117323. PubMed ID: 37852337
[TBL] [Abstract][Full Text] [Related]
37. The Network Pharmacology Study of Dahuang Fuzi Decoction for Treating Incomplete Intestinal Obstruction.
Guo JF; Zhao YT; Du QY; Ren Y; Wang Y; Wang ZX; Jin W
Biomed Res Int; 2022; 2022():2775434. PubMed ID: 35528155
[TBL] [Abstract][Full Text] [Related]
38. Network pharmacology integrated with molecular docking technology to reveal the potential mechanism of Shuganfang against drug-induced liver injury.
Wang Y; Chen X; Wang Y; Zhong H; Liu L; Ye Y
Medicine (Baltimore); 2023 Dec; 102(48):e36349. PubMed ID: 38050247
[TBL] [Abstract][Full Text] [Related]
39. Discussion on the molecular mechanism of Duhuo Jisheng decoction in treating osteoarthritis based on network pharmacology and molecular docking.
Yang L; Zheng S; Hou A; Wang S; Zhang J; Yu H; Wang X; Lan W
Medicine (Baltimore); 2022 Oct; 101(42):e31009. PubMed ID: 36281111
[TBL] [Abstract][Full Text] [Related]
40. Exploring the mechanism of andrographolide in the treatment of gastric cancer through network pharmacology and molecular docking.
Yadav RP; Sadhukhan S; Saha ML; Ghosh S; Das M
Sci Rep; 2022 Nov; 12(1):18413. PubMed ID: 36319798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
